Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
psychedelic drug
Biotech
Compass delays phase 3 psychedelic data, lays off 30% of staff
With the trials overrunning by months, the biotech is laying off 30% of its employees—including some senior managers.
Nick Paul Taylor
Oct 31, 2024 9:00am
Psyence walks away from acquisition of fellow psilocybin biotech
Oct 7, 2024 5:16am
Psyence acquires fellow psilocybin biotech Clairvoyant
Sep 6, 2024 9:25am
PharmAla launches tool aimed at easing access to MDMA drug info
Aug 28, 2024 12:55pm
Lykos caps off chaotic week by cutting 75% of staff
Aug 15, 2024 3:59pm
Lykos' MDMA treatment for PTSD has been quashed at the FDA
Aug 10, 2024 9:07am
